Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, And Forecast To 2030

pa_user-types

Check Today's Best Price

$3500 Buy Now
The Global Influenza Vaccine Market size was valued at $3.99 billion in 2018, and is projected to reach $6.23 billion by 2026, registering a CAGR of 6.43% from 2019 to 2028.
  • Worldwide Influenza Vaccines Market Overview

    The report study researched by Esticast Research gives comprehensive knowledge and valuable insights about the Worldwide Influenza Vaccines Market. Also, the study attempts to deliver significant and detailed insights into the current market prospect and emerging growth scenarios. The report on the Worldwide Influenza Vaccines Market also emphasizes on market players as well as the new entrants in the market landscape.

    The global influenza vaccine market size was valued at $3.99 billion in 2018, and is projected to reach $6.23 billion by 2026, registering a CAGR of 6.43% from 2019 to 2028.

    The Worldwide Influenza Vaccines Market report is a precise and deep-dive study on the current state that aims at the major drivers, market strategies, and imposing growth of the key players. Worldwide Influenza Vaccines Industry also offers a granular study of the dynamics, segmentation, revenue, share forecasts, and allows you to make superior business decisions. The report serves imperative statistics on the market stature of the prominent manufacturers and is an important source of guidance and advice for companies and individuals involved in the Influenza Vaccines industry.

    Impact of Coronavirus (COVID-19) on Worldwide Influenza Vaccines Market.

    Coronavirus (COVID-19) is spreading across the world with a serious impact on the economy and the global market. The report considers and accounts for the impact of COVID-19 on Worldwide Influenza Vaccines Market across all the segments, regions, countries, and key players. North America and Europe are worst-hit countries by Coronavirus which are key players in the global economy. The report provides a detailed analysis of the impact on the market, growth strategies, supply china disruption, consumption pattern of the Worldwide Influenza Vaccines Market.

    Market Segmentation

    The report provides market size with 2019 as the base year in consideration and a yearly forecast until 2030 in terms of Revenue (USD Million). The estimates for all segments including type and application have been provided on a regional basis for the forecast period mentioned above. We have implemented a mix of top-down and bottom-up approaches for market sizing, analyzing the key regional markets, dynamics, and trends for various applications.

    Worldwide Influenza Vaccines Market by Key Segments:

    Global Influenza Vaccine Market, by Vaccine Type

    • Quadrivalent
    • Trivalent

    Global Influenza Vaccine Market, by Technology

    • Egg-based
    • Cell-based

    Global Influenza Vaccine Market, by Type

    • Seasonal
    • Pandemic

    Global Influenza Vaccine Market, by Age Group

    • Pediatric
    • Adult

    Global Influenza Vaccine Market, by Route of Administration

    • Injection
    • Nasal Spray

    Competitive Landscape:

    Key players profile in the report include

    • AstraZeneca
    • FOLIA BIOTECH
    • Sanofi
    • CSL
    • FluGen
    • GlaxoSmithKline
    • Green Cross
    • BionVax
    • Altimmune
    • Genentech
    • SK Chemicals
    • Vaxart
    • Medicago
    • Visterra
    • UNM Pharma
    • Shijiazhuang Yiling Pharmaceutical
    • Moderna Therapeutics
    • Vaxine Pty
    • Vaccitech
    • Novavax

    The report of Worldwide Influenza Vaccines Market studies the key players present in the market. The chapter includes the competitive landscape section which provides the full and in-depth analysis of the current market trends, changing technologies, and developments that will be beneficial for the companies, which are competing in the market. The report offers an overview of revenue, demand, and supply of data, futuristic cost, and growth analysis during the projected year. In addition to a brief overview of the company, analysts shed light on their valuation and evolution. It also discusses the list of important products and the ones in the pipeline. The competitive landscape is analyzed by understanding the approaches of the companies and the initiatives they have taken in recent years to triumph over the intensive competition.

    Regional Analysis

    By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • U.K
      • Germany
      • France
      • Italy
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • South Korea
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Mexico
      • Rest of South America
    • Middle East & Africa
      • GCC Countries
      • Africa
      • Rest of Middle East

    Frequently Asked Questions (FAQ):

    • What is the size of the Worldwide Influenza Vaccines Market?
    • How much will this market be worth from 2020 to 2030?
    • What are the major deals happenings in the Worldwide Influenza Vaccines Market?
    • Which country is expected to hold the highest market share in the Worldwide Influenza Vaccines Market?
    • What are production processes, major issues, and solutions to mitigate the development risk?
    • Who are the top players and what are their activities, revenue, recent developments, and prospects?
    • What are the main drivers and restraints in the Worldwide Influenza Vaccines Market?
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?

    WHO Status:

    Status of vaccine development

    Immunization is the major public health measure for the prevention of influenza virus infection. There are numerous licensed seasonal influenza vaccines available, several of which have been prequalified by the WHO for purchase by UN agencies . There are also several vaccine candidates under development against animal influenza A viruses – influenza strains considered at greatest risk for causing a future pandemic.

    For WHO, the development of vaccines against influenza viruses with pandemic potential, as well as seasonal influenza vaccines that induce broadly protective and long-lasting immune responses are high priorities.

    Challenges to vaccine development

    Due to the constant changing of circulating influenza viruses, influenza vaccines strains are changed annually (for both the Northern Hemisphere and the Southern Hemisphere) to more closely match currently circulating virus strains.

    keyboard_arrow_up
  • Table of Contents

    1 Market Overview
    1.1 Influenza Vaccines Introduction
    1.2 Market Analysis by Type
    1.2.1 Overview: Global Influenza Vaccines Revenue by Type: 2015 VS 2019 VS 2030
    1.2.2 Trivalent Flu Vaccines
    1.2.3 Quadrivalent Flu Vaccines
    1.3 Market Analysis by Application
    1.3.1 Overview: Global Influenza Vaccines Revenue by Application: 2015 VS 2019 VS 2030
    1.3.2 Adults
    1.3.3 Pediatrics
    1.4 Overview of Global Influenza Vaccines Market
    1.4.1 Global Influenza Vaccines Market Status and Outlook (2015-2030)
    1.4.2 North America (United States, Canada and Mexico)
    1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
    1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.5 South America, Middle East & Africa
    1.5 Market Dynamics
    1.5.1 Market Opportunities
    1.5.2 Market Risk
    1.5.3 Market Driving Force
    2 Manufacturers Profiles
    2.1 AstraZeneca
    2.1.1 AstraZeneca Details
    2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
    2.1.3 AstraZeneca SWOT Analysis
    2.1.4 AstraZeneca Product and Services
    2.1.5 AstraZeneca Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.2 FOLIA BIOTECH
    2.2.1 FOLIA BIOTECH Details
    2.2.2 FOLIA BIOTECH Major Business and Total Revenue (Financial Highlights) Analysis
    2.2.3 FOLIA BIOTECH SWOT Analysis
    2.2.4 FOLIA BIOTECH Product and Services
    2.2.5 FOLIA BIOTECH Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.3 Sanofi
    2.3.1 Sanofi Details
    2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
    2.3.3 Sanofi SWOT Analysis
    2.3.4 Sanofi Product and Services
    2.3.5 Sanofi Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.4 CSL
    2.4.1 CSL Details
    2.4.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
    2.4.3 CSL SWOT Analysis
    2.4.4 CSL Product and Services
    2.4.5 CSL Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.5 FluGen
    2.5.1 FluGen Details
    2.5.2 FluGen Major Business and Total Revenue (Financial Highlights) Analysis
    2.5.3 FluGen SWOT Analysis
    2.5.4 FluGen Product and Services
    2.5.5 FluGen Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.6 GlaxoSmithKline
    2.6.1 GlaxoSmithKline Details
    2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
    2.6.3 GlaxoSmithKline SWOT Analysis
    2.6.4 GlaxoSmithKline Product and Services
    2.6.5 GlaxoSmithKline Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.7 Green Cross
    2.7.1 Green Cross Details
    2.7.2 Green Cross Major Business and Total Revenue (Financial Highlights) Analysis
    2.7.3 Green Cross SWOT Analysis
    2.7.4 Green Cross Product and Services
    2.7.5 Green Cross Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.8 BionVax
    2.8.1 BionVax Details
    2.8.2 BionVax Major Business and Total Revenue (Financial Highlights) Analysis
    2.8.3 BionVax SWOT Analysis
    2.8.4 BionVax Product and Services
    2.8.5 BionVax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.9 Altimmune
    2.9.1 Altimmune Details
    2.9.2 Altimmune Major Business and Total Revenue (Financial Highlights) Analysis
    2.9.3 Altimmune SWOT Analysis
    2.9.4 Altimmune Product and Services
    2.9.5 Altimmune Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.10 Genentech
    2.10.1 Genentech Details
    2.10.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
    2.10.3 Genentech SWOT Analysis
    2.10.4 Genentech Product and Services
    2.10.5 Genentech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.11 SK Chemicals
    2.11.1 SK Chemicals Details
    2.11.2 SK Chemicals Major Business and Total Revenue (Financial Highlights) Analysis
    2.11.3 SK Chemicals SWOT Analysis
    2.11.4 SK Chemicals Product and Services
    2.11.5 SK Chemicals Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.12 Vaxart
    2.12.1 Vaxart Details
    2.12.2 Vaxart Major Business and Total Revenue (Financial Highlights) Analysis
    2.12.3 Vaxart SWOT Analysis
    2.12.4 Vaxart Product and Services
    2.12.5 Vaxart Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.13 Medicago
    2.13.1 Medicago Details
    2.13.2 Medicago Major Business and Total Revenue (Financial Highlights) Analysis
    2.13.3 Medicago SWOT Analysis
    2.13.4 Medicago Product and Services
    2.13.5 Medicago Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.14 Visterra
    2.14.1 Visterra Details
    2.14.2 Visterra Major Business and Total Revenue (Financial Highlights) Analysis
    2.14.3 Visterra SWOT Analysis
    2.14.4 Visterra Product and Services
    2.14.5 Visterra Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.15 UNM Pharma
    2.15.1 UNM Pharma Details
    2.15.2 UNM Pharma Major Business and Total Revenue (Financial Highlights) Analysis
    2.15.3 UNM Pharma SWOT Analysis
    2.15.4 UNM Pharma Product and Services
    2.15.5 UNM Pharma Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.16 Shijiazhuang Yiling Pharmaceutical
    2.16.1 Shijiazhuang Yiling Pharmaceutical Details
    2.16.2 Shijiazhuang Yiling Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
    2.16.3 Shijiazhuang Yiling Pharmaceutical SWOT Analysis
    2.16.4 Shijiazhuang Yiling Pharmaceutical Product and Services
    2.16.5 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.17 Moderna Therapeutics
    2.17.1 Moderna Therapeutics Details
    2.17.2 Moderna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
    2.17.3 Moderna Therapeutics SWOT Analysis
    2.17.4 Moderna Therapeutics Product and Services
    2.17.5 Moderna Therapeutics Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.18 Vaxine Pty
    2.18.1 Vaxine Pty Details
    2.18.2 Vaxine Pty Major Business and Total Revenue (Financial Highlights) Analysis
    2.18.3 Vaxine Pty SWOT Analysis
    2.18.4 Vaxine Pty Product and Services
    2.18.5 Vaxine Pty Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.19 Vaccitech
    2.19.1 Vaccitech Details
    2.19.2 Vaccitech Major Business and Total Revenue (Financial Highlights) Analysis
    2.19.3 Vaccitech SWOT Analysis
    2.19.4 Vaccitech Product and Services
    2.19.5 Vaccitech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.20 Novavax
    2.20.1 Novavax Details
    2.20.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
    2.20.3 Novavax SWOT Analysis
    2.20.4 Novavax Product and Services
    2.20.5 Novavax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    3 Sales, Revenue and Market Share by Manufacturer
    3.1 Global Influenza Vaccines Sales and Market Share by Manufacturer (2018-2019)
    3.2 Global Influenza Vaccines Revenue and Market Share by Manufacturer (2018-2019)
    3.3 Market Concentration Rate
    3.3.1 Top 3 Influenza Vaccines Manufacturer Market Share in 2019
    3.3.2 Top 6 Influenza Vaccines Manufacturer Market Share in 2019
    3.4 Market Competition Trend
    4 Global Market Analysis by Regions
    4.1 Global Influenza Vaccines Sales, Revenue and Market Share by Regions
    4.1.1 Global Influenza Vaccines Sales and Market Share by Regions (2015-2020)
    4.1.2 Global Influenza Vaccines Revenue and Market Share by Regions (2015-2020)
    4.2 North America Influenza Vaccines Sales and Growth Rate (2015-2020)
    4.3 Europe Influenza Vaccines Sales and Growth Rate (2015-2020)
    4.4 Asia-Pacific Influenza Vaccines Sales and Growth Rate (2015-2020)
    4.5 South America Influenza Vaccines Sales and Growth Rate (2015-2020)
    4.6 Middle East and Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
    5 North America by Country
    5.1 North America Influenza Vaccines Sales, Revenue and Market Share by Country
    5.1.1 North America Influenza Vaccines Sales and Market Share by Country (2015-2020)
    5.1.2 North America Influenza Vaccines Revenue and Market Share by Country (2015-2020)
    5.2 United States Influenza Vaccines Sales and Growth Rate (2015-2020)
    5.3 Canada Influenza Vaccines Sales and Growth Rate (2015-2020)
    5.4 Mexico Influenza Vaccines Sales and Growth Rate (2015-2020)
    6 Europe by Country
    6.1 Europe Influenza Vaccines Sales, Revenue and Market Share by Country
    6.1.1 Europe Influenza Vaccines Sales and Market Share by Country (2015-2020)
    6.1.2 Europe Influenza Vaccines Revenue and Market Share by Country (2015-2020)
    6.2 Germany Influenza Vaccines Sales and Growth Rate (2015-2020)
    6.3 UK Influenza Vaccines Sales and Growth Rate (2015-2020)
    6.4 France Influenza Vaccines Sales and Growth Rate (2015-2020)
    6.5 Russia Influenza Vaccines Sales and Growth Rate (2015-2020)
    6.6 Italy Influenza Vaccines Sales and Growth Rate (2015-2020)
    7 Asia-Pacific by Regions
    7.1 Asia-Pacific Influenza Vaccines Sales, Revenue and Market Share by Regions
    7.1.1 Asia-Pacific Influenza Vaccines Sales and Market Share by Regions (2015-2020)
    7.1.2 Asia-Pacific Influenza Vaccines Revenue and Market Share by Regions (2015-2020)
    7.2 China Influenza Vaccines Sales and Growth Rate (2015-2020)
    7.3 Japan Influenza Vaccines Sales and Growth Rate (2015-2020)
    7.4 Korea Influenza Vaccines Sales and Growth Rate (2015-2020)
    7.5 India Influenza Vaccines Sales and Growth Rate (2015-2020)
    7.6 Southeast Asia Influenza Vaccines Sales and Growth Rate (2015-2020)
    7.7 Australia Influenza Vaccines Sales and Growth Rate (2015-2020)
    8 South America by Country
    8.1 South America Influenza Vaccines Sales, Revenue and Market Share by Country
    8.1.1 South America Influenza Vaccines Sales and Market Share by Country (2015-2020)
    8.1.2 South America Influenza Vaccines Revenue and Market Share by Country (2015-2020)
    8.2 Brazil Influenza Vaccines Sales and Growth Rate (2015-2020)
    8.3 Argentina Influenza Vaccines Sales and Growth Rate (2015-2020)
    9 Middle East & Africa by Countries
    9.1 Middle East & Africa Influenza Vaccines Sales, Revenue and Market Share by Country
    9.1.1 Middle East & Africa Influenza Vaccines Sales and Market Share by Country (2015-2020)
    9.1.2 Middle East & Africa Influenza Vaccines Revenue and Market Share by Country (2015-2020)
    9.2 Saudi Arabia Influenza Vaccines Sales and Growth Rate (2015-2020)
    9.3 Turkey Influenza Vaccines Sales and Growth Rate (2015-2020)
    9.4 Egypt Influenza Vaccines Sales and Growth Rate (2015-2020)
    9.5 South Africa Influenza Vaccines Sales and Growth Rate (2015-2020)
    10 Market Segment by Type
    10.1 Global Influenza Vaccines Sales and Market Share by Type (2015-2020)
    10.2 Global Influenza Vaccines Revenue and Market Share by Type (2015-2020)
    10.3 Global Influenza Vaccines Price by Type (2015-2020)
    11 Global Influenza Vaccines Market Segment by Application
    11.1 Global Influenza Vaccines Sales Market Share by Application (2015-2020)
    11.2 Global Influenza Vaccines Revenue Market Share by Application (2015-2020)
    11.3 Global Influenza Vaccines Price by Application (2015-2020)
    12 Market Forecast
    12.1 Global Influenza Vaccines Sales, Revenue and Growth Rate (2021-2030)
    12.2 Influenza Vaccines Market Forecast by Regions (2021-2030)
    12.2.1 North America Influenza Vaccines Market Forecast (2021-2030)
    12.2.2 Europe Influenza Vaccines Market Forecast (2021-2030)
    12.2.3 Asia-Pacific Influenza Vaccines Market Forecast (2021-2030)
    12.2.4 South America Influenza Vaccines Market Forecast (2021-2030)
    12.2.5 Middle East & Africa Influenza Vaccines Market Forecast (2021-2030)
    12.3 Influenza Vaccines Market Forecast by Type (2021-2030)
    12.3.1 Global Influenza Vaccines Sales Forecast by Type (2021-2030)
    12.3.2 Global Influenza Vaccines Market Share Forecast by Type (2021-2030)
    12.4 Influenza Vaccines Market Forecast by Application (2021-2030)
    12.4.1 Global Influenza Vaccines Sales Forecast by Application (2021-2030)
    12.4.2 Global Influenza Vaccines Market Share Forecast by Application (2021-2030)
    13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
    13.1.1 Direct Marketing
    13.1.2 Indirect Marketing
    13.2 Distributors, Traders and Dealers
    14 Research Findings and Conclusion
    15 Appendix
    15.1 Methodology
    15.2 Data Source
    15.3 Disclaimer
    15.4 About US

    keyboard_arrow_up
    • AstraZeneca
    • FOLIA BIOTECH
    • Sanofi
    • CSL
    • FluGen
    • GlaxoSmithKline
    • Green Cross
    • BionVax
    • Altimmune
    • Genentech
    • SK Chemicals
    • Vaxart
    • Medicago
    • Visterra
    • UNM Pharma
    • Shijiazhuang Yiling Pharmaceutical
    • Moderna Therapeutics
    • Vaxine Pty
    • Vaccitech
    • Novavax
    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

  • What was the market size of the Influenza Vaccines Market in 2020 and the expected market size by 2026, along with the growth rate?
  • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
  • Which are the largest revenue generating products, services or regions and their comparative growth rate?
  • Which technology is in trend and how would it evolve during the forecast period (2019– 2026)?
  • Which are the leading companies in the Influenza Vaccines Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS

SHARE YOUR CART